Skip to content
RDL Network logo
Correction to Bifunctional Inhibition of Human Immunodeficiency Virus Type 1 Reverse Transcriptase: Mechanism and Proof-of-Concept as a Novel Therapeutic Design Strategy — Christopher M. Bailey (2013) | RDL Network